Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Ibandronate (Sodium Monohydrate) | 138926-19-9 | 98.0% | 1 ML
Supplier: Medchemexpress LLC HYB051510MM/1ML
Ibandronate Sodium Monohydrate is an orally active, selective inhibitor of farnesyl pyrophosphate synthase (FPP synthase). It works by blocking the mevalonate pathway, which inhibits the modification of small GTPases, leading to tumor cell apoptosis and reduced bone resorption. This compound also inhibits tumor cell proliferation, promotes FAS gene expression, and can provide synergistic anti-tumor effects when combined with anti-estrogen compounds. It is commonly used in research related to osteoporosis and bone metastatic tumors, including breast cancer bone metastasis.
- Orally active and selective FPP synthase inhibitor
- Blocks mevalonate pathway
- Induces tumor cell apoptosis
- Inhibits bone resorption
- Inhibits tumor cell proliferation
- Promotes expression of pro-apoptotic gene FAS
- Useful for osteoporosis and bone metastatic tumor research
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?